DealForge autonomously sources, scores, and writes investment memos on venture deals. Stop manually hunting.
1,180+ deals tracked · 22 AI investment memos · Updated daily
Show HN: GBrain, an AI tool for diagnosis and therapy for neurodivergents
Therapy, mood tracking, journaling, informal diagnostics, and a few whizzes for convenience
GBrain addresses a high-growth market in neurodivergent care, but the current profile shows significant risks including a lack of clear technical differentiation and zero recorded traction. The regulatory landscape for 'informal diagnostics' is challenging, and without team or funding data, it remains a high-risk, early-stage concept.